Drug Search Results

Mipsagargin

Alternative Names: mipsagargin, g-202
Latest Update: 2024-05-21
Latest Update Note: Clinical Trial Update

Product Description

Mechanisms of Action: No Mechanism

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Rebus
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 2: Hepatocellular Carcinoma|Glioblastoma|Prostate Cancer|Renal Cell Carcinoma

Phase 1: Skin Cancer

Trial	Phase	Trial Status	Disease	Primary Completion Date
G-202-008	P2	Withdrawn	Glioblastoma	2019-10-01
G-202-004	P2	Completed	Glioblastoma	2016-12-01
G-202-006	P2	Completed	Renal Cell Carcinoma	2016-12-01
G-202-005	P2	Completed	Prostate Cancer	2016-12-01

Recent News Events

Date	Type	Title
02/07/2024	PubMed	Mutation in BrFLS encoding flavonol synthase induced anthocyanin accumulation in Chinese cabbage.
11/10/2023	PubMed	Performance of 'Gala Select' and 'Fuji Suprema' grafted on Geneva series rootstocks under fallow land and replanting conditions in southern Brazil.
10/13/2022	PubMed	Rootstock effects on bitter pit incidence in 'Honeycrisp' apples are associated with changes in fruit's cell wall chemical properties.

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you've used PRYZM, we hope you're able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions